Cargando…

Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects

BACKGROUND: The milk casein-derived biologically active tripeptides, isoleucyl-prolyl-proline (Ile-Pro-Pro) and valyl-prolyl-proline (Val-Pro-Pro), have documented antihypertensive effect probably related to reduced angiotensin formation. It has been suggested that these tripeptides may reduce arter...

Descripción completa

Detalles Bibliográficos
Autores principales: Jauhiainen, T, Rönnback, M, Vapaatalo, H, Wuolle, K, Kautiainen, H, Groop, P-H, Korpela, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857163/
https://www.ncbi.nlm.nih.gov/pubmed/20145666
http://dx.doi.org/10.1038/ejcn.2010.3
_version_ 1782180293488148480
author Jauhiainen, T
Rönnback, M
Vapaatalo, H
Wuolle, K
Kautiainen, H
Groop, P-H
Korpela, R
author_facet Jauhiainen, T
Rönnback, M
Vapaatalo, H
Wuolle, K
Kautiainen, H
Groop, P-H
Korpela, R
author_sort Jauhiainen, T
collection PubMed
description BACKGROUND: The milk casein-derived biologically active tripeptides, isoleucyl-prolyl-proline (Ile-Pro-Pro) and valyl-prolyl-proline (Val-Pro-Pro), have documented antihypertensive effect probably related to reduced angiotensin formation. It has been suggested that these tripeptides may reduce arterial stiffness and improve endothelial function. Our aim was to evaluate whether the milk-based drink containing Ile-Pro-Pro and Val-Pro-Pro influence arterial stiffness, measured as augmentation index (AIx), and endothelial function in man. METHODS: In a double-blind parallel group intervention study, 89 hypertensive subjects received daily peptide milk containing a low dose of tripeptides (5 mg/day) for 12 weeks and a high dose (50 mg/day) for the following 12 weeks, or a placebo milk drink to titrate the dose–response effect. Arterial stiffness was assessed by pulse wave analysis at the beginning and end of each intervention period. Endothelial function was tested by examining pulse wave reflection response to sublingual nitroglycerin and salbutamol inhalation. Blood pressure was measured by using office and 24-h ambulatory blood pressure measurement. RESULTS: At the end of the second intervention period, AIx decreased significantly in the peptide group compared with the placebo group (peptide group −1.53% (95% confidence interval (CI) −2.95 to −0.12), placebo group 1.20% (95% CI 0.09–2.32), P=0·013). No change in endothelial function index was observed (peptide group 0.02 (95% CI −0.06 to 0.08), placebo group 0.04 (95% CI −0.04 to 0.12), P=0.85). There were no statistically significant differences between the effects of the peptide and placebo treatment on office and 24-h ambulatory blood pressure. CONCLUSIONS: Long-term treatment with Lactobacillus helveticus-fermented milk containing bioactive peptides reduces arterial stiffness expressed as AIx in hypertensive subjects.
format Text
id pubmed-2857163
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-28571632010-04-26 Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects Jauhiainen, T Rönnback, M Vapaatalo, H Wuolle, K Kautiainen, H Groop, P-H Korpela, R Eur J Clin Nutr Original Articles BACKGROUND: The milk casein-derived biologically active tripeptides, isoleucyl-prolyl-proline (Ile-Pro-Pro) and valyl-prolyl-proline (Val-Pro-Pro), have documented antihypertensive effect probably related to reduced angiotensin formation. It has been suggested that these tripeptides may reduce arterial stiffness and improve endothelial function. Our aim was to evaluate whether the milk-based drink containing Ile-Pro-Pro and Val-Pro-Pro influence arterial stiffness, measured as augmentation index (AIx), and endothelial function in man. METHODS: In a double-blind parallel group intervention study, 89 hypertensive subjects received daily peptide milk containing a low dose of tripeptides (5 mg/day) for 12 weeks and a high dose (50 mg/day) for the following 12 weeks, or a placebo milk drink to titrate the dose–response effect. Arterial stiffness was assessed by pulse wave analysis at the beginning and end of each intervention period. Endothelial function was tested by examining pulse wave reflection response to sublingual nitroglycerin and salbutamol inhalation. Blood pressure was measured by using office and 24-h ambulatory blood pressure measurement. RESULTS: At the end of the second intervention period, AIx decreased significantly in the peptide group compared with the placebo group (peptide group −1.53% (95% confidence interval (CI) −2.95 to −0.12), placebo group 1.20% (95% CI 0.09–2.32), P=0·013). No change in endothelial function index was observed (peptide group 0.02 (95% CI −0.06 to 0.08), placebo group 0.04 (95% CI −0.04 to 0.12), P=0.85). There were no statistically significant differences between the effects of the peptide and placebo treatment on office and 24-h ambulatory blood pressure. CONCLUSIONS: Long-term treatment with Lactobacillus helveticus-fermented milk containing bioactive peptides reduces arterial stiffness expressed as AIx in hypertensive subjects. Nature Publishing Group 2010-02-10 2010-04 /pmc/articles/PMC2857163/ /pubmed/20145666 http://dx.doi.org/10.1038/ejcn.2010.3 Text en Copyright 2010, Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Licence. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Articles
Jauhiainen, T
Rönnback, M
Vapaatalo, H
Wuolle, K
Kautiainen, H
Groop, P-H
Korpela, R
Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects
title Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects
title_full Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects
title_fullStr Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects
title_full_unstemmed Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects
title_short Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects
title_sort long-term intervention with lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857163/
https://www.ncbi.nlm.nih.gov/pubmed/20145666
http://dx.doi.org/10.1038/ejcn.2010.3
work_keys_str_mv AT jauhiainent longterminterventionwithlactobacillushelveticusfermentedmilkreducesaugmentationindexinhypertensivesubjects
AT ronnbackm longterminterventionwithlactobacillushelveticusfermentedmilkreducesaugmentationindexinhypertensivesubjects
AT vapaataloh longterminterventionwithlactobacillushelveticusfermentedmilkreducesaugmentationindexinhypertensivesubjects
AT wuollek longterminterventionwithlactobacillushelveticusfermentedmilkreducesaugmentationindexinhypertensivesubjects
AT kautiainenh longterminterventionwithlactobacillushelveticusfermentedmilkreducesaugmentationindexinhypertensivesubjects
AT groopph longterminterventionwithlactobacillushelveticusfermentedmilkreducesaugmentationindexinhypertensivesubjects
AT korpelar longterminterventionwithlactobacillushelveticusfermentedmilkreducesaugmentationindexinhypertensivesubjects